FrancophonIA/ELRC3.0 huggingface dataset:
English: Pregabalin has been studied in 3 controlled clinical trials of 12 week duration with BID or TID dosing.
Estonian: Pregabaliini on uuritud 3-es kontrollitud kliinilises uuringus, mis kestsid 12 nädalat annustamisega kaks korda ööpäevas (BID) või kolm korda ööpäevas (TID).
English: Lyrica 225 mg hard capsules White and light orange marked “Pfizer” on the cap and “PGN 225” on the body with black ink.
Estonian: Lyrica 225 mg kõvakapslid Valge ja heleoranž kapsel, mille korgil on musta trükivärviga tähis „Pfizer” ja korpusel „PGN 225”.
English: Each hard capsule contains 100 mg pregabalin.
Estonian: Iga kõvakapsel sisaldab 100 mg pregabaliini.
English: Method of administration Lyrica may be taken with or without food.
Estonian: Lyrica kapsleid võib võtta koos toiduga või ilma.
English: PVC/Aluminium blisters containing 14, 21, 56, 84, or 100 hard capsules.
Estonian: PVC/alumiiniumblisterpakend, mis sisaldab 14, 21, 56, 84 või 100 kõvakapslit.
English: Pregabalin treatment can be started at a dose of 150 mg (7.5 ml) per day given as two or three divided doses.
Estonian: Pregabaliinravi võib alustada annusega 150 mg (7,5 ml) ööpäevas, mis jagatakse kaheks või kolmeks annuseks.
English: Each hard capsule contains 50 mg pregabalin.
Estonian: Iga kõvakapsel sisaldab 50 mg pregabaliini.
English: Based on individual patient response and tolerability, the dose may be increased to 300 mg (15 ml) per day after an interval of 3 to 7 days, and if needed, to a maximum dose of 600 mg (30 ml) per day after an additional 7-day interval.
Estonian: Lähtuvalt individuaalsest ravivastusest ja -taluvusest võib annust 3 kuni 7 päeva möödudes suurendada kuni annuseni 300 mg (15 ml) ööpäevas.
English: PVC/Aluminium blisters containing 14, 21, 56, 84, 100, or 112 hard capsules.
Estonian: PVC/alumiiniumblisterpakend, mis sisaldab 14, 21, 56, 84, 100 või 112 kõvakapslit.
English: Lyrica 300 mg hard capsules White and orange, marked “Pfizer” on the cap and “PGN 300” on the body with black ink.
Estonian: Lyrica 300 mg kõvakapslid Valge ja oranž kapsel, mille korgil on musta trükivärviga tähis „Pfizer” ja korpusel „PGN 300”.
English: • Dry mouth, constipation, vomiting, flatulence, diarrhoea, nausea, swollen abdomen.
Estonian: • Suukuivus, kõhukinnisus, oksendamine, kõhupuhitus, kõhulahtisus, iiveldus, turses kõht
English: Lyrica 100 mg hard capsules Pregabalin
Estonian: Lyrica 100 mg kõvakapslid Pregabaliin
English: PVC/Aluminium blisters containing 14, 56, or 100 hard capsules.
Estonian: PVC/alumiiniumblisterpakend, mis sisaldab 14, 56 või 100 kõvakapslit.
English: Other ingredients include E216 (propyl parahydroxybenzoate) and E218 (methyl parahydroxybenzoate).
Estonian: Ravim sisaldab E216 (propüülparahüdroksübensoaati) ja E218 (metüülparahüdroksübensoaati) Lisainformatsiooni saamiseks lugege infolehte.
English: White marked “Pfizer” on the cap and “PGN 50” on the body with black ink.
Estonian: Valged kõvakapslid, mille peal on tähis „Pfizer“ ja kehal „PGN 50“.Kapsli keha on tähistatud musta ribaga.
English: Posology The dose range is 150 to 600 mg (7.5 to 30 ml) per day given in either two or three divided doses.
Estonian: Annusevahemik on 150...600 mg (7,5 kuni 30 ml) ööpäevas, mis jagatakse kaheks või kolmeks annuseks.
English: • Difficulty breathing, dry nose, nasal congestion.
Estonian: • Hingamisraskused, ninakuivus, kinnine nina
English: Lyrica 225 mg hard capsules
Estonian: Lyrica 225 mg kõvakapslid
English: Lyrica 150 mg hard capsules White marked “Pfizer” on the cap and “PGN 150” on the body with black ink.
Estonian: Lyrica 150 mg kõvakapslid Valge kapsel, mille korgil on musta trükivärviga tähis „Pfizer” ja korpusel „PGN 150”.
English: Bottle immediate packaging for 25 mg hard capsules - pack of 200
Estonian: Pudeli vahetu pakend 25 mg kõvakapslitele - pakendis 200
English: 14 hard capsules 56 hard capsules 70 hard capsules 100 hard capsules 100 x 1 hard capsules 112 hard capsules
Estonian: 14 kõvakapslit 56 kõvakapslit 70 kõvakapslit 100 kõvakapslit 100 x 1 kõvakapslit 112 kõvakapslit
English: Lyrica 25 mg hard capsules White marked “Pfizer” on the cap and “PGN 25” on the body with black ink.
Estonian: Lyrica 25 mg kõvakapslid Valge kapsel, mille peal on musta trükivärviga tähis “Pfizer” ja kehal “PGN 25”.
English: Lyrica 225 mg hard capsules Pregabalin
Estonian: Lyrica 225 mg kõvakapslid Pregabaliin
English: Lyrica 75 mg hard capsules Pregabalin
Estonian: Lyrica 75 mg kõvakapslid Pregabaliin
English: Jaundice
Estonian: Hüperakuusia
English: • Loss of appetite, weight loss, low blood sugar, high blood sugar.
Estonian: • Isutus, kehakaalu vähenemine, madal veresuhkru sisaldus, kõrge veresuhkur
English: Each hard capsule contains 25 mg pregabalin.
Estonian: Iga kõvakapsel sisaldab 25 mg pregabaliini.
English: Lyrica 200 mg hard capsules Pregabalin
Estonian: Lyrica 200 mg kõvakapslid Pregabaliin
English: PVC/Aluminium blisters containing 14, 56, 70 100, or 112 hard capsules.
Estonian: PVC/alumiiniumblisterpakend, mis sisaldab 14, 56, 70, 100 või 112 kõvakapslit.
English: Lyrica 150 mg hard capsules Pregabalin
Estonian: Lyrica 150 mg kõvakapslid Pregabaliin
English: PVC/Aluminium blisters containing 14, 56, 100, or 112 hard capsules.
Estonian: PVC/alumiiniumblisterpakend, mis sisaldab 14, 56, 100 või 112 kõvakapslit.
English: Carton of blister pack (14, 21, 56, 84, 100, and 112) and perforated unit dose blister pack (100) for 25 mg hard capsules.
Estonian: Blisterpakendi karp (14, 21, 56, 84, 100 ja 112) ja ühekordse annusega perforeeritud blisterpakend (100) 25 mg kõvakapslite jaoks.
English: • Change in perception of self, restlessness, depression, agitation, mood swings, difficulty finding words, hallucinations, abnormal dreams, panic attack, apathy, aggression, elevated mood, mental impairment, difficulty with thinking, increase in sexual interest, problems with sexual functioning including inability to achieve a sexual climax, delayed ejaculation.
Estonian: • Iseenese tunnetuse muutused, rahutus, depressioon, agitatsioon, meeleolu kõikumised, raskused sõnade leidmisel, hallutsinatsioonid, ebanormaalsed unenäod, paanikahood, apaatia,
English: 14 hard capsules 56 hard capsules 100 hard capsules 100 x 1 hard capsules
Estonian: 14 kõvakapslit 56 kõvakapslit 100 kõvakapslit 100 x 1 kõvakapslit
English: 14 hard capsules 21 hard capsules 56 hard capsules 84 hard capsules 100 hard capsules 100 x 1 hard capsules 112 hard capsules
Estonian: 14 kõvakapslit 21 kõvakapslit 56 kõvakapslit 84 kõvakapslit 100 kõvakapslit 100 x 1 kõvakapslit 112 kõvakapslit
English: Carton of blister pack (14, 56 or 100) and perforated unit dose blister pack (100) for 225 mg hard capsules
Estonian: Blisterpakendi karp (14, 56 või 100) ja ühekordse annusega perforeeritud blisterpakend (100) 225 mg kõvakapslite jaoks
English: MAH logo
Estonian: Maksakahjustus
English: Lyrica 50 mg hard capsules Pregabalin
Estonian: Lyrica 50 mg kõvakapslid Pregabaliin
English: Pfizer GEP, S.L Tel: +34 91 490 99 00
Estonian: Tel: +34 91 490 99 00
English: Lyrica 75 mg hard capsules
Estonian: Lyrica 75 mg kõvakapslid
English: • Hypersensitivity, swollen face, itchiness, hives, runny nose, nose bleed, cough, snoring.
Estonian: • Ülitundlikkus, näo turse, nahasügelus, nõgeslööve, nohu, ninaverejooks, köha, norskamine
English: Clear colourless liquid
Estonian: Suukaudne lahus Selge värvitu vedelik
English: Blister pack (14, 56 or 100) and perforated unit dose blister pack (100) for 225 mg hard capsules
Estonian: Blisterpakend (14, 56 või 100) ja ühekordse annusega perforeeritud blisterpakend (100) 225 mg kõvakapslite jaoks
English: Lyrica 25 mg hard capsules Pregabalin
Estonian: Lyrica 25 mg kõvakapslid Pregabaliin
English: In addition, Lyrica is available in an HDPE bottle containing 200 capsules for the 25 mg, 75 mg, 150 mg and 300 mg strengths.
Estonian: Lisaks on Lyrica 25 mg, 75 mg, 150 mg ja 300 mg saadaval HDPE pudelis sisaldades 200 kapslit.
English: Lyrica 100 mg hard capsules Orange marked “Pfizer” on the cap and “PGN 100” on the body with black ink.
Estonian: 100 mg kapslid Oranžid kõvakapslid, mille peal on tähis „Pfizer“ ja kehal „PGN 100“.
English: Each hard capsule also contains 24.75 mg lactose monohydrate.
Estonian: Lyrica 225 mg kõvakapslid Iga kõvakapsel sisaldab ka 24,75 mg laktoosmonohüdraati.
English: Carton of blister pack (14, 56, 70, 100, and 112) and perforated unit dose blister pack (100) for 75 mg hard capsules
Estonian: Blisterpakendi karp (14, 56, 70, 100 ja 112) ja ühekordse annusega perforeeritud blisterpakend (100) 75 mg kõvakapslite jaoks
English: Lyrica 300 mg hard capsules Pregabalin
Estonian: Lyrica 300 mg kõvakapslid Pregabaliin
English: Lyrica 200 mg hard capsules Light orange, marked “Pfizer” on the cap and “PGN 200” on the body with black ink.
Estonian: 200 mg kapslid Heleoranžid kõvakapslid, mille peal on tähis „Pfizer“ ja kehal „PGN 200“.
English: 14 hard capsules 21 hard capsules 56 hard capsules 84 hard capsules 100 hard capsules 100 x 1 hard capsules
Estonian: 14 kõvakapslit 21 kõvakapslit 56 kõvakapslit 84 kõvakapslit 100 kõvakapslit 100 x 1 kõvakapslit
English: Blister pack (14, 56, 70, 100 or 112) and perforated unit dose blister pack (100) for 75 mg hard capsules
Estonian: Blisterpakend (14, 56, 70, 100 või 112) ja ühekordse annusega perforeeritud blisterpakend (100) 75 mg kõvakapslite jaoks
English: Blister pack (14, 21, 56, 84, 100, and 112) and perforated unit dose blister pack (100) for 25 mg hard capsules
Estonian: Blisterpakend (14, 21, 56, 84, 100 ja 112) ja ühekordse annusega perforeeritud blisterpakend (100) 25 mg kõvakapslite jaoks
English: Lyrica 200 mg hard capsules
Estonian: Lyrica 200 mg kõvakapslid
English: 14 hard capsules 56 hard capsules 100 hard capsules 100 x 1 hard capsules 112 hard capsules
Estonian: 14 kõvakapslit 56 kõvakapslit 100 kõvakapslit 100 x 1 kõvakapslit 112 kõvakapslit
English: Lyrica 150 mg hard capsules
Estonian: Lyrica 150 mg kõvakapslid
English: Lyrica 20 mg/ml oral solution Pregabalin
Estonian: Lyrica 20 mg/ml suukaudne lahus Pregabaliin
English: First time use only: A Press-In Bottle Adapter (PIBA) is provided with the oral syringe.
Estonian: Suukaudse süstlaga on kaasas sissesurutav pudeli adapter (ingl Press-In Bottle Adapter, PIBA).
English: Each hard capsule also contains 8.25 mg lactose monohydrate.
Estonian: Lyrica 75 mg kõvakapslid Iga kõvakapsel sisaldab ka 8,25 mg laktoosmonohüdraati.
English: Carton of blister pack (14, 56, 100, and 112) and perforated unit dose blister pack (100) for 150 mg hard capsules
Estonian: Blisterpakendi karp (14, 56, 100 ja 112) ja ühekordse annusega perforeeritud blisterpakend (100) 150 mg kõvakapslite jaoks
English: Figure 9
Estonian: Partii nr
English: Carton of blister pack (14, 56, 100, and 112) and perforated unit dose blister pack (100) for 300 mg hard capsules
Estonian: Blisterpakendi karp (14, 56, 100 ja 112) ja ühekordse annusega perforeeritud blisterpakend (100) 300 mg kõvakapslite jaoks
English: Lyrica 50 mg hard capsules
Estonian: Lyrica 50 mg kõvakapslid
English: White hard capsules, with “Pfizer” marked on the cap and “PGN 50”on the body.
Estonian: Valge kapsel, mille korgil on musta trükivärviga tähis „Pfizer” ja korpusel „PGN 50”.
English: Carton of blister pack (14, 21, 56, 84 and 100) and perforated unit dose blister pack (100) for 50 mg hard capsules
Estonian: Blisterpakendi karp (14, 21, 56, 84 ja 100) ja ühekordse annusega perforeeritud blisterpakend (100) 50 mg kõvakapslite jaoks
English: Blister pack (14, 56, 100 or 112) and perforated unit dose blister pack (100) for 150 mg hard capsules
Estonian: Blisterpakend (14, 56, 100 või 112) ja ühekordse annusega perforeeritud blisterpakend (100) 150 mg kõvakapslite jaoks
English: Blister pack (14, 56, 100 or 112) and perforated unit dose blister pack (100) for 300 mg hard capsules
Estonian: Blisterpakend (14, 56, 100 või 112) ja ühekordse annusega perforeeritud blisterpakend (100) 300 mg kõvakapslite jaoks
English: Infections and infestations Common
Estonian: Organsüsteemi klassid Kõrvaltoime Infektsioonid ja infestatsioonid Sage
English: Carton of blister pack (21, 84 or 100) and perforated unit dose blister pack (100) for 200 mg hard capsules
Estonian: Blisterpakendi karp (21, 84 või 100) ja ühekordse annusega perforeeritud blisterpakend (100) 200 mg kõvakapslite jaoks
English: neutropaenia, increase in blood creatinine, decrease in blood potassium).
Estonian: kreatiniinisisalduse suurenemine, kaaliumisisalduse vähenemine)
English: Blister pack (14, 21, 56, 84 and 100) and perforated unit dose blister pack (100) for 50 mg hard capsules
Estonian: Blisterpakend (14, 21, 56, 84 ja 100) ja ühekordse annusega perforeeritud blisterpakend (100) 50 mg kõvakapslite jaoks
English: White and orange hard capsules with “Pfizer” marked on the cap and “PGN 75” on the body.
Estonian: 75 mg kapslid Valged/oranžid kõvakapslid, mille peal on tähis „Pfizer“ ja kehal „PGN 75“.
English: Lyrica 300 mg hard capsules
Estonian: Lyrica 300 mg kõvakapslid
English: Lyrica 25 mg hard capsules
Estonian: Lyrica 25 mg kõvakapslid
English: Carton of blister pack (21, 84 or 100) and perforated unit dose blister pack (100) for 100 mg hard capsules
Estonian: Blisterpakendi karp (21, 84 või 100) ja ühekordse annusega perforeeritud blisterpakend (100) 100 mg kõvakapslite jaoks
English: • Allergic reactions (which may include difficulty breathing, inflammation of the eyes (keratitis)
Estonian: • Allergilised reaktsioonid, näiteks hingamisraskused, silma sarvkesta põletik (keratiit) ja tõsine nahareaktsioon, mida iseloomustavad lööve, villid, kestendav nahk ja valu
English: Capsules
Estonian: Kapslid
English: Blister pack (21, 84 or 100) and perforated unit dose blister pack (100) for 200 mg hard capsules
Estonian: Blisterpakend (21, 84 või 100) ja ühekordse annusega perforeeritud blisterpakend (100) 200 mg kõvakapslite jaoks
English: • Difficulties with erection.
Estonian: • Erektsioonihäired
English: ANNEX I
Estonian: III LISA
English: Blister pack (21, 84 or 100) and perforated unit dose blister pack (100) for 100 mg hard capsules
Estonian: Blisterpakend (21, 84 või 100) ja ühekordse annusega perforeeritud blisterpakend (100) 100 mg kõvakapslite jaoks
English: White and light orange hard capsules, with “Pfizer” marked on the cap and “PGN 225” on the body.
Estonian: Valged/heleoranžid kõvakapslid, mille peal on tähis „Pfizer“ ja kehal „PGN
English: Each hard capsule also contains 35 mg lactose monohydrate.
Estonian: Lyrica 25 mg kõvakapslid Iga kõvakapsel sisaldab ka 35 mg laktoosmonohüdraati.
English: Insert the syringe into the PIBA and draw out the required volume from the inverted bottle
Estonian: Lükake süstal PIBA-sse ja tõmmake ümberpööratud pudelist välja vajalik kogus ravimit (joonised 3 ja 4).
English: Each hard capsule also contains 33 mg lactose monohydrate.
Estonian: Lyrica 300 mg kõvakapslid Iga kõvakapsel sisaldab ka 33 mg laktoosmonohüdraati.
English: White hard capsules, with “Pfizer” marked on the cap and “PGN 150” on the body.
Estonian: 150 mg kapslid Valged kõvakapslid, mille peal on tähis „Pfizer“ ja kehal „PGN 150“.
English: C.
Estonian: Märkus.
English: Printing ink:
Estonian: Trükivärv:
English: AUTHORISATION
Estonian: Vertiigo
English: The full EPAR for Zoledronic Acid Hospira can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst ravimi Zoledronic Acid Hospira kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: When used to prevent bone complications, the infusion can be repeated every three to four weeks, and patients should also take supplements of calcium and vitamin D.
Estonian: Kui ravimit kasutatakse luutüsistuste ennetamiseks, tohib infusiooni korrata iga 3-4 nädala järel ning patsiendid peavad võtma lisaks ka kaltsiumi ja D-vitamiini.
English: This leads to less disease activity in Paget's disease.
Estonian: Selle tulemuseks on haiguse väiksem aktiivsus luu Pageti tõve korral.
English: Patients must have adequate fluids before and after treatment, and should receive adequate supplements of vitamin D and calcium.
Estonian: Patsiendile tuleb enne ja pärast ravi manustada piisavalt vedelikku ning täiendavalt piisavalt D-vitamiini ja kaltsiumi.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Zoledronic Acid Hospira on 19 November 2012.
Estonian: Euroopa Komisjon andis ravimi Zoledronic Acid Hospira müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 19. novembril 2012.
English: For more information on generic and hybrid medicines, see the question-and-answer document here.
Estonian: Lisateave geneeriliste ja hübriidravimite kohta on teabedokumendis siin.
English: This is a long-term disease where the normal process of bone growth is altered, which causes bones to become weakened or deformed.
Estonian: See on krooniline haigus, mille korral on luukoe normaalne moodustumine häiritud ja luud nõrgenevad või deformeeruvad.
English: A risk management plan has been developed to ensure that Zoledronic Acid Hospira is used as safely as possible.
Estonian: Töötati välja riskijuhtimiskava, et tagada ravimi Zoledronic Acid Hospira võimalikult ohutu kasutamine.
English: Therefore, the CHMP's view was that, as for Zometa and Aclasta, the benefit outweighs the identified risks.
Estonian: Seetõttu on inimravimite komitee arvamusel, et nagu ka Zometa ja Aclasta korral, ületab ravimi kasulikkus sellega kaasnevad riskid.
English: An additional infusion, given at least one year after the first one, can be considered if the patient's disease comes back.
Estonian: Kui haigus taastub, võib kaaluda ka lisainfusiooni manustamist vähemalt aasta pärast esimest infusiooni.
English: The CHMP concluded that, in accordance with EU requirements, Zoledronic Acid Hospira has been shown to be comparable to Zometa and Aclasta.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Zoledronic Acid Hospira võrreldavus ravimitega Zometa ja Aclasta.
English: This includes fractures (breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), bone disorders needing radiotherapy (treatment with radiation) or surgery, and hypercalcaemia (high levels of calcium in the blood).
Estonian: Luutüsistused on näiteks luumurrud, seljaaju kompressioon (seljaaju pitsumine luude vahel), kiiritusravi või kirurgilist sekkumist vajavad luukahjustused ja hüperkaltseemia (vere liigne kaltsiumisisaldus).
English: What measures are being taken to ensure the safe and effective use of Zoledronic Acid Hospira?
Estonian: Mis meetmed võetakse, et tagada ravimi Zoledronic Acid Hospira ohutu ja efektiivne kasutamine?
English: For more information about treatment with Zoledronic Acid Hospira, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate ravimiga Zoledronic Acid Hospira toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Zoledronic Acid Hospira.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Zoledronic Acid Hospira, including the appropriate precautions to be followed by healthcare professionals and patients.
Estonian: Selle alusel lisati ravimi Zoledronic Acid Hospira omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
English: No additional studies were needed as Zoledronic Acid Hospira is given by infusion and contains the same active substance as the reference medicines, Zometa and Aclasta.
Estonian: Lisauuringuid ei olnud vaja, sest Zoledronic Acid Hospira on infusioonina manustatav geneeriline ravim, mis sisaldab sama toimeainet kui võrdlusravimid Zometa ja Aclasta.
English: Because Zoledronic Acid Hospira is given by infusion and contains the same active substance as the reference medicines, its benefits and risks are taken as being the same as the reference medicines'.
Estonian: Et ravimit Zoledronic Acid Hospira manustatakse infusioonina ja see sisaldab sama toimetainet kui võrdlusravimid, peetakse selle kasulikkust ja riske samadeks mis võrdlusravimil.
English: It is available as a concentrate (4 mg/5 ml) to be made up into a solution for infusion (drip) into a vein, and as solutions for infusion (4 mg/100 ml and 5 mg/100 ml).
Estonian: Seda turustatakse infusioonilahuse (veeni tilgutatava lahuse) kontsentraadina (4 mg/5 ml) ja infusioonilahustena (4 mg/100 ml ja 5 mg/100 ml).
English: For the treatment of Paget's disease of the bone, Zoledronic Acid Hospira is given as one infusion lasting at least 15 minutes.
Estonian: Luu Pageti haiguse ravis manustatakse ravimit Zoledronic Acid Hospira ühe vähemalt 15 minutit kestva infusioonina.
English: This means that it is similar to one or more ‘reference medicines' already authorised in the European Union (EU).
Estonian: See tähendab, et Zoledronic Acid Hospira on sarnane ühe või mitme võrdlusravimiga, millel juba on Euroopa Liidus müügiluba.
English: The company provided data from the published literature on zoledronic acid.
Estonian: Ettevõte esitas soledroonhappe kohta avaldatud kirjandusest pärinevad andmed.
English: This is a summary of the European public assessment report (EPAR) for Zoledronic Acid Hospira.
Estonian: See on ravimi Zoledronic Acid Hospira Euroopa avaliku hindamisaruande kokkuvõte.
English: Zoledronic Acid Hospira 5 mg/100 ml solution is used to treat Paget's disease of the bone in adults.
Estonian: Ravimi Zoledronic Acid Hospira 5 mg/100 ml lahust kasutatakse ka luu Pageti tõve raviks täiskasvanutel.
English: For the prevention of bone complications and treatment of hypercalcaemia caused by tumours, the usual dose of Zoledronic Acid Hospira is one infusion of 4 mg over at least 15 minutes.
Estonian: Luutüsistuste ennetamiseks ja kasvajast põhjustatud hüperkaltseemia ravis on ravimi Zoledronic Acid Hospira tavaannus üks 4 mg infusioon vähemalt 15 minuti jooksul.
English: By preventing the breakdown of bones, Zoledronic Acid Hospira also helps to reduce the amount of calcium released into the blood.
Estonian: Luukoe lagunemist peatades aitab Zoledronic Acid Hospira vähendada verre eralduva kaltsiumi kogust.
English: The Committee recommended that Zoledronic Acid Hospira be given marketing authorisation.
Estonian: Komitee soovitas anda ravimi Zoledronic Acid Hospira müügiloa.
English: Zoledronic Acid Hospira 4 mg/5 ml concentrate and 4 mg/100 ml solution are used to prevent bone complications in adults with advanced cancer that is affecting the bone.
Estonian: Ravimi Zoledronic Acid Hospira 4 mg/5 ml kontsentraati ja 4 mg/100 ml lahust kasutatakse luud kahjustava kaugelearenenud vähiga täiskasvanutel luutüsistuste ennetamiseks.
English: Zoledronic Acid Hospira is a medicine that contains the active substance zoledronic acid.
Estonian: Zoledronic Acid Hospira on ravim, mis sisaldab toimeainena soledroonhapet.
English: They can also be used to treat the hypercalcaemia caused by tumours.
Estonian: Kontsentraati ja lahust tohib kasutada ka kasvajast põhjustatud hüperkaltseemia raviks.
English: Other information about Zoledronic Acid Hospira
Estonian: Muu teave ravimi Zoledronic Acid Hospira kohta
English: The reference medicine for the 4 mg/5 ml concentrate and 4 mg/100 ml solution is Zometa.
Estonian: 4 mg/5 ml kontsentraadi ja 4 mg/100 ml lahuse võrdlusravim on Zometa.
English: Zoledronic Acid Hospira is a ‘generic' and a ‘hybrid' medicine.
Estonian: Zoledronic Acid Hospira on geneeriline ja hübriidravim.
English: What is Zoledronic Acid Hospira?
Estonian: Mis on Zoledronic Acid Hospira?
English: Why has Zoledronic Acid Hospira been approved?
Estonian: Miks Zoledronic Acid Hospira heaks kiideti?